CDKN2A and central nervous system cancer: Concerning specific drivers of glioma progression, recurrent IDH mutant-noncodel gliomas presented an enrichment in CDKN2A homozygous deletions, with subsequent DNA aneuploidy and genetic instability that were associated with shorter OS [101].